| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d574f68011b2a49282a0ae98ca328f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50d9c3b606c93d3e676d47f39d6cdf6a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685 |
| filingDate |
2006-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f291ca871bde0668e2c7ad101e0c044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1db6a10a4676fa96d7efb2ef6c7a0fc0 |
| publicationDate |
2008-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1919484-A1 |
| titleOfInvention |
Use of dha in the form of phospholipids for the preparation of a composition that is intended for the treatment of respiratory failure |
| abstract |
The invention relates to the use of at least one phospholipid having at least one docosahexaenoyl (DHA) residue, such as a lecithin-DHA-type phospholipid, for the preparation of an enteral composition that is intended for the treatment and/or prevention of respiratory failure, particularly in humans. |
| priorityDate |
2005-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |